Novo Nordisk - Oxford Fellowship Programme
The Novo Nordisk – Oxford Fellowship Programme aims to support the development of a new generation of exceptional researchers in the field of diabetes and other cardiometabolic diseases, who will become future leaders in the field.
The Novo Nordisk – Oxford Fellowship Programme is focused on research in diabetes, cardiometabolism, liver and renal disease. It aims to support the development of a new generation of exceptional early career researchers, who will become future leaders in the field, while further developing scientific excellence and ultimately improving the lives of patients. We offer prestigious 3-year postdoctoral research fellowship positions in research projects that span the translational spectrum, from basic biological research through to clinical application.
What we offer
We offer fellows a cutting edge research project based at the University of Oxford, which is supervised by world-leading researchers in the field of diabetes and other cardiometabolic diseases. In addition, each fellow is given a mentor or supervisor at Novo Nordisk. There is also the opportunity to spend time in the laboratories of Novo Nordisk (both in Oxford and Denmark). This distribution of time will depend on the fellow's specific project. Fellows will therefore get an insight into research in both academia and industry.
Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility.
Burrage MK. et al, (2022), Cardiovasc Drugs Ther
A neuroimmunometabolic view on the cephalic phase of insulin release.
Sarker G. and Domingos AI., (2022), Cell Metab, 34, 940 - 942
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents.
Hazlehurst JM. et al, (2022), Metabol Open, 14
The effects of endogenously- and exogenously-induced hyperketonemia on exercise performance and adaptation.
Dearlove DJ. et al, (2022), Physiol Rep, 10